ClinicalTrials.gg

Program

moponetug

Also written as “BMS-986446”, “BMS-986446 IV” and “BMS-986446 SC”.

Its studies are mostly in Alzheimer Disease, led by Bristol-Myers Squibb.

Furthest: phase 2, since Feb 13, 20245 company-led studies, 3 open or runningNext primary completion: Dec 17, 2026 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Bristol-Myers Squibb53 open or runningphase 2since Feb 13, 2024Oct 10, 2023Dec 17, 2026phase 2 · NCT06268886
  • Named in Bristol-Myers Squibb’s own pipeline as moponetug, phase 2, as of Oct 29, 2026 (source).

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Oct 10, 2023First study: phase 1 study in Healthy ParticipantsFirst studyNCT06084598 · 24 enrolled · United States
  2. Feb 13, 2024Phase 2 study in Alzheimer DiseaseNCT06268886 · 310 enrolled · United States, Australia, Belgium and more
  3. Apr 25, 2025Phase 1 study in Healthy VolunteerNCT06955741 · 46 enrolled · United States
  4. Aug 19, 2026Phase 1 study in Alzheimer DiseaseNCT07780383 · 84 planned · United States
  5. Sep 24, 2026Phase 1 study in Healthy VolunteersNCT07852962 · 10 planned

Ahead

  1. Dec 17, 2026Primary completion: phase 2 study in Alzheimer DiseaseNCT06268886
  2. Jun 17, 2027Primary completion: phase 1 study in Alzheimer DiseaseNCT07780383
  3. Jul 18, 2027Primary completion: phase 1 study in Healthy VolunteersNCT07852962

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 5 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07852962Healthy Volunteers1Not yet recruitingJul 18, 202710
NCT07780383Alzheimer Disease · United States1RecruitingJun 17, 202784
NCT06955741Healthy Volunteer · United States1CompletedSep 11, 202546
NCT06268886Alzheimer Disease · United States, Australia, Belgium and more2Active, not recruitingDec 17, 2026310
NCT06084598Healthy Participants · United States1CompletedMar 8, 202424

How it is read

Names in the registry

  • “BMS-986446”, 4 entries
  • “BMS-986446 IV”, 1 entry
  • “BMS-986446 SC”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.